Article
Identification of COX5B as a novel biomarker in high-grade glioma patients
1 Nov 2017
Abstract excerpt
Background: Malignant glioma is the second leading cause of cancer-related death worldwide, and is known to exhibit a high degree of heterogeneity in its deregulation of different oncogenic pathways. The molecular subclasses of human glioma are not well known. Thus, it is crucial to identify vital oncogenic pathways in glioma with significant relationships to patient survival. Methods: In this study, we devised a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
